The estimated Net Worth of Thomas M Abate is at least $4.64 Million dollars as of 7 May 2013. Thomas Abate owns over 15,000 units of Edwards Lifesciences Corp stock worth over $4,210,274 and over the last 19 years Thomas sold EW stock worth over $427,695.
Thomas has made over 17 trades of the Edwards Lifesciences Corp stock since 2011, according to the Form 4 filled with the SEC. Most recently Thomas exercised 15,000 units of EW stock worth $329,400 on 7 May 2013.
The largest trade Thomas's ever made was exercising 60,000 units of Edwards Lifesciences Corp stock on 26 July 2012 worth over $1,310,400. On average, Thomas trades about 6,148 units every 18 days since 2006. As of 7 May 2013 Thomas still owns at least 61,689 units of Edwards Lifesciences Corp stock.
You can see the complete history of Thomas Abate stock trades at the bottom of the page.
Thomas's mailing address filed with the SEC is C/O EDWARDS LIFESCIENCES, ONE EDWARDS WAY, IRVINE, CA, 92614.
Over the last 21 years, insiders at Edwards Lifesciences Corp have traded over $94,964,396 worth of Edwards Lifesciences Corp stock and bought 47,398 units worth $3,992,090 . The most active insiders traders include Michael A Mussallem, Donald E Jr Bobo, and Steven R Loranger. On average, Edwards Lifesciences Corp executives and independent directors trade stock every 8 days with the average trade being worth of $1,126,057. The most recent stock trade was executed by Donald E Jr Bobo on 11 September 2024, trading 5,000 units of EW stock currently worth $226,400.
edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.
Edwards Lifesciences Corp executives and other stock owners filed with the SEC include: